🔬
You have used your free lookups for today
Upgrade to BiotechSigns Pro for unlimited company access, full signal history, watchlist alerts, and 125+ PDUFA dates.
Upgrade to Pro →← Back to screener
← Back to Screener
R

RNAC

Cartesian Therapeutics, Inc.
Biotech / PharmaScore: 51/100📋 Full Profile
C
51
Analyst Summary
Verified 2026-04-11

Cartesian Therapeutics, Inc. Common Stock (RNAC) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

RNAC has 3 Form 4 insider filings recorded at the SEC in the past 30 days[1].

Sources

  1. SEC EDGAR · 0001453687 (2026-04-11) ↗
Not financial advice. BiotechSigns scores are for informational purposes only and do not constitute investment recommendations. Always do your own due diligence before making investment decisions.
No active signals for RNAC
Signal Summary
PDUFA0
Insider0
Clinical0
Data Sources
DilutionWatch○ PENDING
StonkWhisper○ PENDING
SEC EDGAR● LIVE
ClinicalTrials● LIVE
Yahoo Finance● LIVE